'Our Aim Is To Scout And Spot Untapped Rural Students Potentials'

Pulsus currently focusses towards expanding healthcare informatics and pharmacovigilance market studies of the current and future prospects of the global healthcare market. Dr Srinubabu, CEO Pulsus HealthTech, reveals more in an interaction with Express Pharma

- Dr Srinubabu,

Can you explain the idea behind Pulsus HealthTech?

Pulsus Group is a health informatics and healthcare services company and publisher of scientific, technical, and medical literatures. It was established in 1984 primarily to publish peer-reviewed medical journals. Pulsus Group conducts conferences in association with scientific societies.

Pulsus Group is a medical and healthcare publisher since three decades and received accolades from the contributors and the readers. At present, Pulsus Group is diversifying its publishing portfolio to other realms by incorporating all major science, technology, medical journals as an ardent scientific publisher of open access and hybrid access peer reviewed journals. With a view to preserve, pursue, share and distribute scientific discoveries and knowledge, Pulsus currently focusses towards expanding healthcare informatics and pharma covigilance market studies of the current and future prospects of the global healthcare market.

Pulsus was focussing on American region and presently expanding to healthcare informatics platform to the medical and pharma professionals throughout Europe, America, Asia, Australia and all other continents. Since its inception, Pulsus received endorsements of medical associations and industries of international repute. This support allowed Pulsus Group to gain excellent reputation from the scientific and industrial community and able to bridge relations between industries and practicing physicians.

Pulsus Pharma covigilance works including collection, archival and monitoring of individual case study reports, studies with reference to four phases of clinical research and development of existing and emerging molecules, adverse drug reaction reports, effectiveness and risk factors assessment.